 Twist Bioscience Corporation NASDAQ: TWST has announced a broad-based research collaboration with Boehringer Ingelheim International GmbH. The collaboration will use Twists proprietary antibody libraries to discover therapeutic antibodies against multiple targets provided by Boehringer Ingelheim. 